Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | ANS014004 |
Synonyms | |
Therapy Description |
ANS014004 is a small molecule MET inhibitor with activity against MET D1228A and Y1230H, which potentially inhibits tumor cell proliferation and tumor growth (Mol Cancer Ther (2023) 22 (12_Supplement): C145). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
ANS014004 | ANS 014004|ANS-014004 | MET Inhibitor 59 | ANS014004 is a small molecule MET inhibitor with activity against MET D1228A and Y1230H, which potentially inhibits tumor cell proliferation and tumor growth (Mol Cancer Ther (2023) 22 (12_Supplement): C145). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06307795 | Phase I | ANS014004 | A Study to Investigate ANS014004 in Participants With Locally Advanced or Metastatic Solid Tumors | Not yet recruiting | USA | 0 |